Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Rheumatology International|March 10, 2022
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort studyYoichi Nakayama, Ryu Watanabe, Kosaku Murakami, et al.
Rheumatology (Oxford, England)|March 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER CohortKohei Tsujimoto, Kosuke Ebina, Satomi Okamura, et al.
Rheumatology (Oxford, England)|November 10, 2025
Baseline neutrophil-to-lymphocyte ratio predicts drug retention of IL-6 inhibitors and JAK inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuhei Fujisawa, Ryu Watanabe, Tadashi Okano, et al.
Joint Bone Spine|May 27, 2026
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
Arthritis Research & Therapy|November 22, 2025
Does perioperative discontinuation of anti-rheumatic drugs increase postoperative complications in orthopedic surgery for rheumatoid arthritis?Hiromu Ito, Hajime Ishikawa, Shigeyoshi Tsuji, et al.
Rheumatology (Oxford, England)|February 6, 2024
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Shuhei Hattori, et al.
RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
Rheumatology (Oxford, England)|May 9, 2024
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort studyRyu Watanabe, Kosuke Ebina, Takaho Gon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibilityHui Jin, Noriko Arase, Kouyuki Hirayasu, et al.
Modern Rheumatology|March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
Pageof 16